LDL-apheresis; potential procedure for prevention and regression of atheromatous vascular lesion.
Nine patients with familial hypercholesterolemia (FH), 6 with homozygotes and 3 with heterozygotes, were treated with long term repetitive LDL-apheresis. The techniques are simple plasma exchange with human albumin solution, double membrane filtration, and selective LDL-adsorption by dextran sulfate-cellulose gel. The average term was 3.5 years except for the two homozygotes for whom the treatment was only initiated in our facility. Plasma total cholesterol levels were controlled between pretreating level, 320 to 500 mg/dl, and posttreating level, 100 to 160 mg/dl, by biweekly treatments. All patients showed remarkable improvement of cutaneous and tendinous xanthomas. One homozygous patient died at 31 years old of myocardial infarction after 2 years of treatment. A homozygous patient who has been treated since 5 years old for 6 years was reexamined by angiography and was shown to have atheromatous lesions regressed in the aortic valve region and in the left renal artery.
Yokoyama
S
S
Department of Etiology and Pathophysiology, National Cardiovascular Center, Osaka, Japan.
Yamamoto
A
A
Hayashi
R
R
Satani
M
M
D001161:Arteriosclerosis / Q000628:therapy; D001781:Blood Component Removal; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000150:complications / Q000628:therapy*; D008077:Lipoproteins, LDL; D008297:Male
D008077:Lipoproteins, LDL; D002784:Cholesterol